Pentixapharm completes oversubscribed private placement, raises EUR 20.4 million gross

Reuters2026/07/27 20:06

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Pentixapharm completed a rights offering. A subsequent private placement was substantially oversubscribed.
All 11,020,221 new shares were placed with existing shareholders, new investors.
Gross proceeds totaled about EUR 20.4 million. Net proceeds were about EUR 19.65 million.
Share capital is set to rise to EUR 35,815,689 on registration of the capital increase.
Proceeds earmarked for the PANDA Phase 3 program, US expansion, platform development, manufacturing scale-up, equity strengthening, working capital beyond Q1 2027.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pentixapharm Holding AG published the original content used to generate this news brief on July 27, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Pentixapharm completes oversubscribed private placement, raises EUR 20.4 million gross

You may also like

Crypto prices